A Review of the Mechanisms of Action of the Herbal Medicine, STW 5‐II, Underlying Its Efficacy in Disorders of Gut–Brain Interaction
Neurogastroenterology & Motility · 2026
DOI: 10.1111/nmo.70047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurogastroenterology & Motility, 2026. Verfasst von Anita Annaházi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Zoology, Technical University of Munich, Freising, Germany. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Dyspepsia, Brain-Gut Axis, Brain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Functional dyspepsia (FD) and irritable bowel syndrome (IBS) are disorders of gut–brain interaction (DGBIs). Patients with these disorders experience abdominal symptoms, frequently in relation to meal intake, and often are treated using pharmacological approaches that offer limited symptom relief. In addition to various pharmacotherapies, established treatment options include lifestyle modifications (such as diet) and, in certain patients, psychological interventions. Because of the limitations of the currently available treatments, many patients look for alternative options, including herbal preparations.
Purpose
In this review, we summarize the preclinical and clinical evidence informing the use of the herbal preparation, STW 5‐II, for the treatment of patients with FD and IBS. Data from clinical trials provide evidence that STW 5‐II is superior to placebo in offering symptom relief. Moreover, a substantial body of preclinical data on the mechanisms of action of STW 5‐II suggests that its ingredients target multiple mechanisms relevant to pathophysiology and symptom generation that may underlie its beneficial clinical effects in patients with DGBIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair of Zoology, Technical University of Munich, Freising, Germany.
- Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria.
- Department of Pharmaceutical Biology, Johannes Gutenberg University, Mainz, Germany.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Chair of Human Biology, Technical University of Munich, Freising, Germany.
- Synergy Research and Experimental Medicine Research Group, Medical Clinic III, University Hospital Bonn, Bonn, Germany.
ORCID-Profile: Christine Feinle-Bisset
Zitieren
APA
Annaházi, A., Bauer, R., Efferth, T., Khayyal, M. T., Schemann, M., Ulrich-Merzenich, G., & Feinle-Bisset, C. (2026). A Review of the Mechanisms of Action of the Herbal Medicine, STW 5‐II, Underlying Its Efficacy in Disorders of Gut–Brain Interaction. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.70047
Vancouver
Annaházi A, Bauer R, Efferth T, Khayyal MT, Schemann M, Ulrich-Merzenich G, et al. A Review of the Mechanisms of Action of the Herbal Medicine, STW 5‐II, Underlying Its Efficacy in Disorders of Gut–Brain Interaction. Neurogastroenterology & Motility. 2026. doi:10.1111/nmo.70047
BibTeX
@article{Annahzi2026,
author = {Annaházi, Anita and Bauer, Rudolf and Efferth, Thomas and Khayyal, Mohamed T and Schemann, Michael and Ulrich-Merzenich, Gudrun and Feinle-Bisset, Christine},
title = {A Review of the Mechanisms of Action of the Herbal Medicine, STW 5‐II, Underlying Its Efficacy in Disorders of Gut–Brain Interaction},
journal = {Neurogastroenterology & Motility},
year = {2026},
doi = {10.1111/nmo.70047}
}
EUVIMED